Stephen F. Carroll

5.4k total citations · 1 hit paper
75 papers, 4.2k citations indexed

About

Stephen F. Carroll is a scholar working on Immunology, Molecular Biology and Biotechnology. According to data from OpenAlex, Stephen F. Carroll has authored 75 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Immunology, 33 papers in Molecular Biology and 18 papers in Biotechnology. Recurrent topics in Stephen F. Carroll's work include Toxin Mechanisms and Immunotoxins (28 papers), Immune Response and Inflammation (17 papers) and Transgenic Plants and Applications (15 papers). Stephen F. Carroll is often cited by papers focused on Toxin Mechanisms and Immunotoxins (28 papers), Immune Response and Inflammation (17 papers) and Transgenic Plants and Applications (15 papers). Stephen F. Carroll collaborates with scholars based in United States, Germany and Australia. Stephen F. Carroll's co-authors include R. John Collier, David Eisenberg, Lesa J. Beamer, Viloya S. Allured, David McKay, Ulrich Seydel, Patrick J. Scannon, Mark White, John E. Palardy and Nicolas A. Parejo and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Stephen F. Carroll

73 papers receiving 4.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Relationship between Plasma Levels of Lipopolysaccharide (LPS) and LPS‐Binding Protein in Patients with Severe Sepsis and Septic Shock

1999 505 citations Patrick J. Scannon, Mark White et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen F. Carroll United States	33	2.5k	1.4k	700	676	585	75	4.2k
Steven B. Mizel United States	46	4.4k 1.8×	2.6k 1.9×	386 0.6×	908 1.3×	212 0.4×	76	7.9k
Christina Cheers Australia	38	3.0k 1.2×	779 0.6×	230 0.3×	988 1.5×	378 0.6×	101	5.0k
John L. Ryan United States	33	2.5k 1.0×	1.6k 1.2×	299 0.4×	952 1.4×	131 0.2×	92	5.6k
Edward A. Havell United States	33	2.3k 0.9×	1.1k 0.8×	189 0.3×	1.1k 1.6×	421 0.7×	74	4.6k
Peter F. Mühlradt Germany	36	4.0k 1.6×	1.7k 1.3×	1.2k 1.8×	1.1k 1.6×	102 0.2×	97	6.1k
Örjan Ouchterlony Sweden	17	1.5k 0.6×	2.0k 1.4×	222 0.3×	738 1.1×	212 0.4×	56	5.9k
Terje E. Michaelsen Norway	54	2.4k 1.0×	3.1k 2.3×	810 1.2×	1.0k 1.5×	242 0.4×	239	8.1k
Gary T. Jennings Switzerland	25	1.6k 0.6×	1.6k 1.1×	217 0.3×	793 1.2×	307 0.5×	36	4.1k
Masao Mitsuyama Japan	36	2.0k 0.8×	1.4k 1.0×	233 0.3×	847 1.3×	704 1.2×	154	4.6k
Aldo Tagliabue Italy	36	2.3k 0.9×	885 0.7×	345 0.5×	487 0.7×	107 0.2×	131	3.9k

Countries citing papers authored by Stephen F. Carroll

Since Specialization

Citations

This map shows the geographic impact of Stephen F. Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen F. Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen F. Carroll more than expected).

Fields of papers citing papers by Stephen F. Carroll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen F. Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen F. Carroll. The network helps show where Stephen F. Carroll may publish in the future.

Co-authorship network of co-authors of Stephen F. Carroll

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen F. Carroll. A scholar is included among the top collaborators of Stephen F. Carroll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen F. Carroll. Stephen F. Carroll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yimam, Kidist, Alan Bonder, Kessendri Reddy, et al.. (2025). Alkaline Phosphatase Changes With Seladelpar Across Subgroups Of Primary Biliary Cholangitis Patients In The Response Trial. Digestive and Liver Disease. 57. S88–S88.

Strohl, William R., et al.. (2022). Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants. BioDrugs. 36(3). 231–323. 28 indexed citations

Baliga, Ramesh, Keyu Li, Paul R. Hinton, et al.. (2020). Abstract 5664: A bispecific IgM antibody format for enhanced T cell dependent killing with minimal cytokine release. Cancer Research. 80(16_Supplement). 5664–5664. 3 indexed citations

Oda, Michael N., et al.. (2013). NanoDisk containing super aggregated amphotericin B: a high therapeutic index antifungal formulation with enhanced potency. International Journal of Nanomedicine. 8. 4733–4733. 21 indexed citations

Rodger, Jennifer, et al.. (2007). Slow Release Formulations of Triamcinolone Acetonide (TA) for Intra-Vitreal Injection Provide Sustained TA Concentrations in a Rabbit Pharmacokinetic Model. Investigative Ophthalmology & Visual Science. 48(13). 5808–5808. 1 indexed citations

Levy, Ofer, Richard B. Sisson, Donald A. Goldmann, et al.. (2002). Neutrophil defense in patients undergoing bone marrow transplantation: bactericidal/permeability-increasing protein (BPI) and defensins in graft-derived neutrophils1. Transplantation. 73(9). 1522–1526. 10 indexed citations

Gutsmann, Thomas, et al.. (2001). Interaction between Lipopolysaccharide (LPS), LPS-Binding Protein (LBP), and Planar Membranes. Biological Chemistry. 382(3). 425–34. 37 indexed citations

Horwitz, Arnold H., et al.. (2000). Inclusion of S-Sepharose Beads in the Culture Medium Significantly Improves Recovery of Secreted rBPI21 from Transfected CHO-K1 Cells. Protein Expression and Purification. 18(1). 77–85. 7 indexed citations

Giroir, Brett P., Phil Barton, Erica A. Kirsch, et al.. (1997). Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis. The Lancet. 350(9089). 1439–1443. 140 indexed citations

10.

Bauer, Robert J., Scott D. Leigh, C Birr, et al.. (1996). ALTERATION OF THE PHARMACOKINETICS OF SMALL PROTEINS BY IODINATION. Biopharmaceutics & Drug Disposition. 17(9). 761–774. 14 indexed citations

11.

Better, Marc, Susan L. Bernhard, Robert E. Williams, et al.. (1995). T Cell-targeted Immunofusion Proteins from Escherichia coli. Journal of Biological Chemistry. 270(25). 14951–14957. 9 indexed citations

12.

Fishwild, Dianne M., et al.. (1994). Characterization of the increased cytotoxicity of gelonin anti-T cell immunoconjugates compared with ricin A chain immunoconjugates. Clinical & Experimental Immunology. 97(1). 10–18. 9 indexed citations

13.

Gazzano-Santoro, Hélène, Károly Mészáros, C Birr, et al.. (1994). Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria. Infection and Immunity. 62(4). 1185–1191. 72 indexed citations

14.

Carroll, Stephen F., et al.. (1994). Enhanced Stability in vitro and in vivo of Immunoconjugates Prepared with 5-Methyl-2-iminothiolane. Bioconjugate Chemistry. 5(3). 248–256. 12 indexed citations

15.

Blazar, Bruce R., Raphael Hirsch, R E Gress, Stephen F. Carroll, & Daniel A. Vallera. (1991). In vivo administration of anti-CD3 monoclonal antibodies or immunotoxins in murine recipients of allogeneic T cell-depleted marrow for the promotion of engraftment. The Journal of Immunology. 147(5). 1492–1503. 36 indexed citations

16.

Trown, Patrick W., et al.. (1991). Improved pharmacokinetics and tumor localization of immunotoxins constructed with the Mr 30,000 form of ricin A chain.. PubMed. 51(16). 4219–25. 25 indexed citations

17.

Carroll, Stephen F., Joseph Barbieri, & R. John Collier. (1988). [11] Diphtheria toxin: Purification and properties. Methods in enzymology on CD-ROM/Methods in enzymology. 165. 68–76. 47 indexed citations

18.

Carroll, Stephen F. & R. John Collier. (1988). [31] Diphtheria toxin: Quantification and assay. Methods in enzymology on CD-ROM/Methods in enzymology. 165. 218–225. 21 indexed citations

19.

Barbieri, Joseph, Stephen F. Carroll, R. John Collier, & J. A. MCCLOSKEY. (1981). An endogenous dinucleotide bound to diphtheria toxin. Adenylyl-(3',5')-uridine 3'-monophosphate.. Journal of Biological Chemistry. 256(23). 12247–12251. 30 indexed citations

20.

Carroll, Stephen F. & Rafael J. Martinez. (1981). Antibacterial peptide from normal rabbit serum. 1. Isolation from whole serum, activity, and microbicidal spectrum. Biochemistry. 20(21). 5973–5981. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact